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K+ channels selectively transport K+ ions across cell membranes and play a key role in regulating the physiology of excitable and
nonexcitable cells. Their activation allows the cell to repolarize after action potential firing and reduces excitability, whereas channel
inhibition increases excitability. In eukaryotes, the pharmacology and pore topology of several structural classes of K+ channels
have been well characterized in the past two decades. This information has come about through the extensive use of scorpion
toxins. We have participated in the isolation and in the characterization of several structurally distinct families of scorpion toxin
peptides exhibiting different K+ channel blocking functions. In particular, the venom from the Moroccan scorpion Androctonus
mauretanicus mauretanicus provided several high-affinity blockers selective for diverse K+ channels (SKCa, Kv4.x, and Kv1.x K+
channel families). In this paper, we summarize our work on these toxin/channel interactions.
1. The Scorpion Venom Content
Scorpion venoms are very complex mixtures of molecules,
constituting a diverse, naturally occurring peptide library,
with most peptides displaying different kinds of biological
activity [1, 2]. These peptides can specifically bind to a vari-
ety of pharmacological targets, in particular ion channels,
resulting in neurotoxic effects. Toxins modulating Na+, K+,
Ca++, and Cl− currents have been described in scorpion
venoms [2].
Toxins that are highly lethal for mammals modify vol-
tage-gated Na+ (Nav) currents in excitable cells and are
referred to as “Nav channel long-chain toxin.” These toxins
are single-chain, small, basic peptides (60- to 75-amino-acid
residue chain generally folded by four disulfide bridges).
They have been described as α- or β-toxins due to their
binding site on Nav channels as well as to their pharmaco-
logical effects [1, 3]. α-Toxins bind in a voltage-dependent
manner on the voltage sensor of the Nav channel domain
IV and inhibit the inactivation phase of the action potential.
β-Toxins act on the channel activation phase by binding
to extracellular loops located preferentially on the voltage
sensor of the Nav channel domain II (but also occasionally
of domain III) [1, 3–6].
Another class of scorpion toxins has also been widely
studied, even if these toxins are devoid of serious lethal effect.
They block different K+ channel subtypes (some of them in
the picomolar range) and are so-called “K+ channel toxins”
[1, 2, 7]. They are usually shorter than Nav channel toxins
but are structurally closely related to them. These Nav and
K+ channels toxins share a common dense scaffold typically
formed by an α-helix and a β-sheet stabilized by disulfide
bridges [8].
Several components of scorpion venom that act on Cl−
and Ca++ channels have also been described [2]. However,
they have little or no influence on the venom toxicity for
mammals.
This overview will focus, in particular, on our work
done on the K+ channel blockers purified from the Androc-
tonus mauretanicus mauretanicus venom, which were among
the first K+ channel blockers characterized from scorpion
venoms.
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2. K+ Channel Blockers from Scorpion Venoms
K+ channels constitute a ubiquitous family of transmem-
brane proteins which play a key role in the regulation
of a wide variety of physiological processes involved in
cell excitability, including regulation of heart beat, muscle
contraction, neurotransmitter release, hormonal secretion,
signal transduction, and cell proliferation [9]. Multiple
combinations of K+ channels result from the ability of
their subunits to coassemble as tetramers, thus considerably
increasing the total number of functionally distinct K+ chan-
nels. According to their functional and gating properties, K+
channels have been first divided into four groups: voltage-
activated, Ca2+-activated, inward rectifier, and two-pore K+
channels [10]. Their 3D architecture has now been depicted
by X-ray crystallography [11].
K+ channel blocker’s toxins (KTxs) from scorpion ven-
oms are short peptides, which are made usually of about
28–40-amino-acid residues reticulated by three or four
disulfide bridges, forming compact and resistant molecules
[7]. They have been invaluable tools for understanding the
physiological role of K+ channels and have been exploited
to gain insights into the structure of the channel pore that
they occlude via electrostatic and hydrophobic interactions
[12, 13]. They block K+ channels from the extracellular
side and bind to their outer vestibules. In most cases, they
possess at least two functionally crucial residues: examples
include a lysine residue that plugs the channel pore with its
side chain and a hydrophobic residue that strengthens the
interaction between the toxin and its target. These residues
are found in very low concentrations in the venoms (from
0.01 to 1% by weight of crude venom) and have almost no
toxic effects in mice when injected by subcutaneous route.
However, some of them could be very toxic following direct
intracerebroventricular injection.
Based on primary amino acid sequences and cysteine
pairing, KTxs have been classified into four families, the α-,
β-, γ-, and κ-KTx [2, 7]. So far more than 120 KTxs, ranging
from 23 to 64 amino acids, have been isolated and sequenced.
Most of their structures exhibit a common minimal motif,
named the “Cystein-Stabilized-Helix” (CSH). As found in
Buthidae scorpions, long and short toxins consist of one
α-helix and two or three β-strands, in which two disulfide
bridges covalently link a segment of the α-helix with one
strand of the β-sheet structure [8]. Even if their amino acid
sequences are different, the conserved peptide fold allows
insertions, deletions, and mutations conferring to the toxins
diverse selectivity and affinity for their target. Only the
recently characterized κ-KTxs are formed by two parallel α-
helices linked by two disulfide bridges [14].
The α-KTx family is the largest one and is divided into
at least 22 subfamilies, defined according to the primary
sequence alignments of the toxins. Each member has diverse,
specific blocking activities against voltage-gated (Kv) and
calcium-activated (KCa) channels. Most of the α-KTxs bind
to the ion channel vestibule through the β-sheet side of their
structure.
Other, longer peptides, with 45- to 68-amino acid
residues and cross-linked by three disulfide bridges, have
been characterized and classified as the β-KTx family. They
possess two structural and functional domains: an N-
terminal α-helix (with cytolytic or antimicrobial activity
like the insect defensins) and a tightly folded C-terminal
region with the CSH motif (displaying K+ channel-blocking
activities [15]). Finally, the γ-KTx family was described as
specifically targeting hERG channels [16].
3. The Androctonus mauretanicus
mauretanicus Venom
Scorpion stings in Morocco are the primary cause of
envenomation and constitute a largely underestimated health
problem. An epidemiologic study of four regions of the
Moroccan Kingdom, where scorpion stings are prevalent,
showed that the stings are mainly due to the black scor-
pion Androctonus mauretanicus mauretanicus (83% of the
reported cases). Children, in desert areas far from medical
centers, were the primary victims, with casualty rates up
to 8% in those under ten years old. The Androctonus
mauretanicus mauretanicus venom is one of the most toxic
Buthidae venoms ever described (its median lethal dose
ranges from 0.05 to 0.2mg/kg by subcutaneous injection in
mice) and immunotherapy remains the treatment of choice
[17].
Previous fractionation studies of the venom allowed
identification of several toxins that are active on different
Nav or Kv channels [18–22]. At least several major proteins,
considered highly toxic to mice, have already been purified
and chemically and pharmacologically characterized as clas-
sical α-toxins [18, 19]. All together, these toxins represent
about 28% of the absorbance (wavelength 280 nm) of the
crude venom and 73% of the total lethality for mice. The
most represented and the most lethal classical α-toxin Amm
V alone constitutes 11% of the absorbance and 47% of the
total lethality.
However, other toxins isolated from the Androctonus
mauretanicus mauretanicus venom gained popularity as
powerful tools because they have displayed some of the
highest binding affinity and specificity for K+ channels. They
have been extensively used to investigate the mechanisms
of ion conduction and channel selectivity, as well as the
architecture of the pore region. Finally, significant advances
have been made by using solid-state NMR data to construct
3D structures from Kaliotoxin (KTX) in complex with
a chimeric K+ channel KcsA-Kv1.3 [13]. These studies
allowed direct investigation of the molecular rearrangements
associated with KTX binding on both the channel selectivity
filter and the KTX itself.
A recentMALDI-TOFmass spectrometry (MS) study has
provided new information about the molecular composition
of scorpion venom [23]. Through the developments in
proteomics, MS is now widely used for accurate and sensitive
determinations of molecular masses and identification of
heterogenous complex mixtures such as crude venoms.
Using an offline MALDI-TOF/MS analysis, we were able
to determine the molecular masses of about 70 to 80
different compounds ranging between 3000 and 8000Da in
an Androctonus mauretanicus mauretanicus venom obtained
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under manual stimulation from a pool of animals kept alive
at the “Pasteur Institute” of Casablanca, Morocco. Figure 1
presents the snapshot of this crude venom.
4. The Smallest Toxins Identified so Far in the
Androctonus mauretanicus mauretanicus
Venom: P01 (α-KTx8) and P05 (α-KTx5),
Ligands of SKCa Channels
P01 (α-KTx 8.1 subfamily, 3177Da) is devoid of significant
toxicity in mouse [26]. This toxin of 28-amino-acid residues,
which is the smallest K+ channels ligand in the Androctonus
mauretanicus mauretanicus venom, is slightly negatively
charged with acidic amino acids localized at the beginning
of the β-turn and extending along the α-helix (Figure 2(a)).
Surprisingly, P01 presents exactly the same sequence in
Androctonus mauretanicus mauretanicus, Androctonus aus-
tralis, Androctonus amoreuxi, and Buthus occitanus venoms.
Usually, the polymorphism among scorpion toxins is so high
that their sequences vary from a scorpion subspecies to
another, even in the same structural, pharmacological, and
immunological family. P01 is a poor-affinity ligand (300 nM)
for the apamin-binding site on rat brain synaptosomes. In
comparison, apamin purified from the bee venom displays
a very high affinity (Kd = 8 pM) for its target, that is,
the small-conductance calcium-activated K+ channel (SKCa)
channel so-called apamin-sensitive channel. Since the first
P01 characterization, other closely related analogs have been
purified from other Buthidae venoms. Among them, one is
particularly interesting because it shares 89% of identity with
P01. This analog, called OdK1, was purified from the Iranian
scorpion Odontobuthus doriae (α-KTx 8.5 subfamily). OdK1
is able to block Kv1.2 channels expressed in oocytes with
a median inhibition concentration (IC50) value of 183 nM
and has no effect on Kv1.1, Kv1.3, Kv1.4, Kv1.5, and the
Shaker channels [27]. It is important to mention that P01 has
not been tested yet on Kv1.2 channels in electrophysiological
experiments. P01 was only shown unable to compete with
125I-KTX (a Kv1.1 and Kv1.3 and not Kv1.2 blocker) bound
to its receptor on rat brain synaptosomes. Thus, we cannot
totally exclude that P01 could exhibit a poor Kv1.2 blocking
activity. In the same line, OdK1 activity on SKCa channels has
not been tested yet either.
In contrast to P01, P05, another toxin from Androc-
tonus mauretanicus mauretanicus, is a high-affinity selective
ligand (Kd = 100 pM) for the apamin-binding site on rat
brain synaptosomes, and it has no effects on BKCa or Kv
channels. P05 is a 31-amino-acid long peptide (3415Da),
which belongs to the α-KTx5.x’s family (as Leiurotoxin1
or Scyllatoxin from the venom of the scorpion Leiurus
quinquestriatus Hebraeus) (Figure 2(b)) [29, 30]. The toxins
from this family have only two-stranded β-sheet because
of their short N-terminal side [28]. P05 is highly toxic
(14 ng, i.e., 4 pmols for a 20 g mouse) and leads to an
epileptic behavior when injected in mouse by the intracere-
broventricular route. P05 possesses a short stretch of four
amino acids similar to the one in the apamin sequence,
which constitutes a highly positively charged region in the
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Figure 1: MALDI-TOF mass spectra of pool venom manually
extracted from Androctonus mauretanicus mauretanicus. K+ channel
blockers and voltage-gated Na+ channels modulators are indicated.
P01 and P05, blockers of SKCa channels; AmmTX3, blockers of Kv4
and hERG channels; KTX, Kv1.1, and Kv1.3 blockers. Amm III and
Amm V are major lethal α-toxins; β-toxins specific for insects are
also mentioned. The 3D structure of KTX (left) and of the α-toxin
of reference AaH II from Androctonus australis (right) are shown
[13, 24, 25]. The Cys-Stabilized-Helix (CSH)motif is shown in inset
[8].
α-helix (containing in particular two Arg residues, Arg7
and Arg9) exposed to solvent. Extensive structure-function
studies using chemically synthesized analogs revealed that
these two Arg were critical for P05’s interaction with its target
as described for apamin [31].When Arg were replaced by Lys,
the activity dropped by a factor of one hundred, and when
they were replaced by Ile, the affinity decreased even more to
a Kd value in the micromolar range. Moreover, α-amidation
of His in P05 C-terminal conferred a large gain of function
leading to an almost irreversible binding to its receptor
[21]. When the apamin C-terminal residue is in the free
carboxylic form, only 0.06% of the pharmacological activity
of the native C-amidated apamin is retained [32]. Both
Arg and C-terminal His create a strong positive electrostatic
potential, which drives the toxin to negative residues (Asp)
of the channel pore. Using homology-modeling models of
SK channels (rsk1, rsk2, and rsk3) and Brownian dynamics
methods, the recognition between P05 and its targets was
investigated [33]. It was found that the rsk2 channel,
presenting the highest frequencies and lowest electrostatic
interaction energies, was the most favorable target for P05
binding, while rsk3 was intermediate, and rsk1 was the least
favorable. From the P05-rsk2 complex model, it was shown
that P05 probably locates around the extracellular pore of
SK channels and assures the contact with rsk2 channel using
critical basic amino acid residues in its α-helix: Arg6 (P05)-
Asp364 (SK), Arg7 (P05)-Asn368 (SK), and Arg13 (P05)-Asp341
and Asp364 (SK). Further refinements of P05-rsk2 complex
model using molecular mechanics showed that six hydrogen
bonding interactions exist between P05 and the rsk2 channel.
These simulation results were in good agreement with our
previous in vivo binding experiments and could explain
4 Journal of Toxicology
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Figure 2: Amino acid sequences and 3D structures of P01 and P05.
(a) Amino acid sequence (single letter notation) and 3D structure
of P01 [26, 28]. (b) Amino acid sequence (single letter notation) of
P05 compared to that of the bee venom apamin (18 mers peptide).
Amino acids common to P05 and apamin and crucial for the SKCa
blockade are in blue. These amino acids are materialized on the 3D
structure of P05, view by the α-helix axe. The two positive Arg are
in blue and the neutral Gln is in brown.
the interaction between P05 and SK channels at the level of
the molecular structure.
5. The Most Noted K+ Channel Blocker
Characterized in the Androctonus
mauretanicus mauretanicus Venom:
Kaliotoxin (α-KTx3 Subfamily)
The Kaliotoxin (KTX, 4150Da) purified from the venom
of the Androctonus mauretanicus mauretanicus was the first
identified member of the α-KTx3.1 subfamily, which is
currently composed of 13 highly homolog members sharing
more than 75% sequence identity. KTX was first described
as a BKCa low-affinity blocker [20], but further analysis
showed that KTX blocked more specifically Kv1.3 channels
with a very high affinity (Kd = 10 pM) and Kv1.1 with
a much weaker affinity (in the 10 nM range). KTX also
exhibited a functional blockade of Ca2+-activated K+ Gardos
channel from rabbit or human red blood cells with a
median inhibition concentration value of 5 nM. Interaction
between this channel and other peptide toxins indicated
that the Ga´rdos channel was pharmacologically different in
several interesting ways from the other Ca2+-activated K+
channels [34]. Interestingly, KTX was not toxic in mice by
subcutaneous injection up to 500 micrograms (100 nmols),
but intracerebroventricularly injected mice showed tremor,
paralysis, and death with a median lethal dose of only 24 ng
of KTX (about 6 pmol for a 20 g mouse).
KTX was then widely used by different international
groups to probe the vestibule topology from the lymphocyte
Kv1.3 channel. The homotetrameric Kv1.3 channel controls
the resting potential membrane in T cells and plays a crucial
role in human T-lymphocyte activation [35]. Its inhibition
causes depolarization and an attenuation of the rise in the
intracellular Ca2+ concentration that is required for T-cell
activation. Accordingly, Kv1.3 channel is a good therapeutic
target for the development of immunosuppressant drugs. It
is important to note that Kv1.3 channel is a key mediator of
multiple sclerosis, type 1 diabetes mellitus, and rheumatoid
arthritis pathologies [36]. In experimental autoimmune
encephalomyelitis (EAE) rat, animal model for multiple
sclerosis, KTX was capable of immunosuppressant activity
in vivo. Addition of KTX during Antigen/T-cell activation
led to a large reduction of the T-cell proliferative response, a
decreased encephalitogenicity of T cells, and finally improved
the symptoms of EAE [37].
A new therapeutic approach for inflammatory bone
resorption by targeting Kv1.3 was also investigated and the
potential effect of KTX was tested on inflammatory lesions
of periodontal disease. These lesions contain abundant
activated/memory T and B cells, which control immuno-
logical interactive networks and accelerate bone resorption.
Systemic KTX administration finally resulted in an 84%
decrease of the bone resorption. These results suggested that
KTX could also constitute a potential therapy to prevent
alveolar bone loss in periodontal disease [38].
Monoiodinated derivative of KTX (125I-KTX) binds
specifically to rat brain total membranes with a maximal
binding capacity of about 14 fmol/mg of protein and with
a high affinity (Kd = 80 pM). The distribution of 125I-KTX
binding sites in rat brain was first studied using quantitative
autoradiography on adult brain tissue sections. A compar-
ison with the distribution of Kv1.1 and Kv1.3 α-subunits
by immunohistochemistry or in situ hybridization suggested
that KTX recognizes channels containing these subunits [39].
Further, we used KTX injected by intracerebroventricular
route to rat brain in order to investigate the involvement
of Kv channels containing Kv1.1 and Kv1.3 α-subunits in
olfactory associative learning and memory. KTX facilitated
cognitive processes as learning, in particular in a reference
representation [40]. Therefore, it is likely that KTX-sensitive
Kv channels contribute to the repolarization of action poten-
tials at presynaptic terminals of hippocampal inhibitory
neurons and induce facilitation of the transmission.
Concerning the KTX structure-function relationship
studies, they were first performed using synthetic analogs
such as KTX(1−37), KTX(1−37)-amide and short peptides includ-
ing KTX(27−37), KTX(25−32), and KTX(1−11). Concerning the
short peptides, which corresponded to secondary structural
elements, only KTX(27−37) and KTX(25−32)were able to com-
pete with 125I-KTX for its receptor on rat brain synaptosomes
and act as antagonists of KTX. These results demonstrated
for the first time that the C-terminal region, particularly
the toxin β-sheet, was involved in the interaction with the
Journal of Toxicology 5
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Figure 3: Amino acid sequence and 3D structure of KTX. The
crucial amino acid residues involved in the receptor recognition are
in red and are materialized on the 3D structure according to Lange
et al., 2006 [13]. The α-helix is in green, the β-sheet in red. Arrows in
red indicate the three peptides able to compete (Kd = 100 nM) with
the 125I-KTX bound to its binding site on rat brain synaptosomes
[41].
receptor and the channel blockade [41]. Figure 3 summarizes
these results.
Several international groups also produced KTX and
numerous mutants using chemical synthesis or heterologous
expression, in order to identify KTX residues implicated in
the specific interaction with Kv1.3 channels. It was found
that the side chain of Lys27 of the toxin enters deeply into
the channel pore and interacts with the Asp402 residue of
each subunit [24]. Briefly, the KTX residues involved in
the interaction with the channel were Arg24, Phe25, Lys27,
Met39, Asn30, Arg31. All these residues were present in the
short peptides that we first used to demonstrate the β-sheet
importance in the channel blockade. A model also predicted
that Ser11 of the KTX made steric contacts with His404 and
Pro405 of the α-subunit IV of the Kv1.3 and Thr36 with His404
of the opposing Kv1.3 α-subunit [42].
KTX binding to a chimeric K+ channel (KcsA-Kv1.3) in
proteoliposomes was investigated using solid-state nuclear
magnetic resonance (ssNMR) [13]. Upon complex for-
mation, significant chemical shift changes of the residues
implicated in the specific interaction were observed for both
KTX and chimeric channel. For KTX, the conformational
changes involved mainly β-sheet contacts between the first
and third β-strand and for the chimeric channel it affected
the conformation of both the pore helix and the selectivity
filter. The backbone conformation of Kcsa-Kv1.3 selectivity
filter adopted a novel structure with features of both the
conducting and collapsed conformation of the KcsA. The
ssNMR data directly showed that Asp64 in the KcsA-Kv1.3
vestibule represented an important interaction site for KTX.
Large chemical shift changes were seen for Gly77, Tyr78, and
Gly79 in the selectivity filter and also for the side chains of
Glu71 and Asp80 that form carboxyl-carboxylate pairs on the
backside of the filter [13]. Finally, an enhanced backbone
mobility was detected for two glycine residues within the
selectivity filter that are highly conserved amongst potassium
channels and are of core relevance to the filter structure and
ion selectivity [43, 44].
Combination of additional ssNMR studies, dynamic
simulations, and electrophysiological measurements finally
revealed the complete mechanism of KTX binding to its
receptor site and showed a structural link between inactiva-
tion and block of the channel. A mechanism of cooperative
toxin-induced conformational changes that are structurally
and functionally related to recovery from C-type inactiva-
tion, would be the consequence of the very tight interac-
tion between KTX and Kcsa-Kv1.3. The KTX affinity was
lowered by about 20-fold when the Kv1.3 channels entered in
C-type inactivation probably due to changes of the interac-
tion surface between the toxin and the channel [43–45].
All these recent ssNMR data obtained between the
chimeric KcsA-Kv1.3 channel and KTX have largely con-
tributed to decrypt the intimate interaction between a K+
channel blocker and its target, as well as to better understand
the blockade of the K+ conduction.
6. The α-KTx15 Subfamily: Janus Kv4.x
and hERG Blockers
The first member of the α-KTx15 subfamily characterized
was Aa1 from the Androctonus australis venom (3869Da)
[46]. At the primary sequence level, the toxin has an
unusual N-terminal pyroglutamic acid, like Charybdotoxin
and Iberiotoxin, but the rest of its sequence was totally
original. Aa1 completely blocked a fast IA-type K+ current
from cerebellum granular cells. Using whole-cell patch clamp
recording on striatal neurons in culture, we selected another
novel toxin, BmTX3 from Buthus martensii, which was also
able to block a fast IA-type K+ current. The sustained current
was unaffected with a micromolar dose of toxin whereas the
IA-type K+ current completely disappeared independently of
the membrane potential. Autoradiograms of adult rat brain
sections demonstrated a highly heterogeneous distribution
of 125I-BmTX3 binding sites throughout the adult rat brain.
High density of receptors was found in the striatum, the
CA1 and CA3 field of the hippocampus, the superior
colliculus, and in the granular layer of the cerebellum [47].
We then purified AmmTX3 (3827Da), an analog of Aa1
and BmTX3, from the venom of Androctonus mauretanicus
mauretanicus [22]. Latter, several cDNAs encoding two
Aa1 isoforms, AaTX1 (3867Da) and AaTX2 (3853Da),
were identified by PCR amplification from a venom gland
cDNA library of Androctonus australis [48]. Also, another
oligonucleotide sequence, AamTX (3751Da), was amplified
from a venom gland cDNA library of Androctonus amoreuxi
[49]. Altogether these toxins constitute the first members of
the α-KTx15 subfamily (Figure 4). From a pharmacological
point of view, theses toxins were unable to compete with
any other already described toxins purified from animal
venom. However, they were toxic in mouse at high doses by
intracerebral injections and induced epileptic status, which
6 Journal of Toxicology
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Figure 4: Amino acid sequences of the toxins from the α-KTx15
subfamily. Aa1 [46], AaTX1, and AaTX2 [48] are from Androctonus
australis; BmTX3 [47] is from Buthus martensii; AmmTX3 [22] is
from Androctonus mauretanicus; AamTX [49] is from Androctonus
amoreuxi. Discrepin [54] is from the Venezuelan scorpion Tityus
discrepans. Single letter notation is used for amino acid sequences.
Z is pyroglutamic acid. ∗Indicates putative amino acid sequence
deduced from cloned cDNA oligonucleotide sequence. The β-sheet
consensus sequence is in grey.
could last 24 to 48 hours. Also, they all shared the same target
on rat brain synaptosomes because they competed with
each other for the same binding site. The nature of the K+
channels blocked by AmmTX3 was assessed by performing
whole-cell patch recording of the K+ currents of striatal
neurons and of cerebellum granular cells in culture. In all
cases, AmmTX3 inactivated the transient A-current without
affecting the sustained K+ current, as observed for Aa1 and
BmTX3. As well described, A-type K+-currents result mainly
from the expression of voltage-dependent Kv α-subunits
(Kv1.4, 3.4, 4.1, 4.2, 4.3) or from the association of Kv β-
subunit with Kv1 α-subunits [50, 51]. In the cerebellum
granular cells, the voltage-gated K+ channels Kv4 of the
Shal subfamily elicits A-type currents. These channels are
fast transient K+ channels that regulate the kinetics of the
action potential [51, 52]. The localizations of Kv4 subunits
and their auxiliary subunits were similar to the distribution
of BmTX3 binding sites in numerous regions of the brain.
For example, the high density of BmTX3 binding sites in
the CA1 field and CA3 field followed Kv4.2 and Kv4.3
immunostaining patterns. In the molecular layer of the
dendate gyrus, the BmTX3 binding pattern was also similar
to the immunoreactivity pattern of Kv4 and KChIP subunits,
with a higher density in distal dendrites of the granular layer
than in the more proximal dendrite areas [53].
Finally, electrophysiological analysis of mammalian cells
expressing different A-type channels showed that BmTX3
completely inhibited the rapidly activating and inactivat-
ing Kv4.1 current in a voltage-independent manner. This
inhibition was less effective on Kv4.2 and Kv4.3 channels
and the toxin did not show any effects on other tran-
sient currents elicited by Kv1.4 and Kv3.4 [53]. Recent
electrophysiological studies using acute coronal midbrain
slices and AmmTX3 confirmed that the targets of the α-
KTx15 subfamily are Kv4 channels [55, Rudy B, personal
communication]. Interestingly, the radioiodinated α-KTx15
toxins bound to their receptor on rat brain neurons were
not displaced by any spider toxin, which block Kv4 channels.
This result suggests that these scorpion and spider Kv4
blockers have different binding sites. The α-KTx15 toxins
most probably block the Kv4 channel pore because tarantula
toxins inhibit Kv4 channels by binding to the voltage-sensor
paddles (crucial helix-turn-helix motifs within the voltage-
sensing domains composed of the S3b and S4 helices)
[56]. Moreover, deletions of the last two BmTx3 C-terminal
residues (α-KTx15 subfamily) were made to assess the role of
the penultimate Tyr residue in the receptor recognition. This
Tyr resembled to the canonical dyad previously proposed
as necessary to block the K+ channel conduction with high
efficacy. Our results showed that the truncated toxin bound
to its receptor less efficiently than the wild-type toxin (by
a factor of about 105) and had no more channel blocking
activity [57]. All these results suggest that the Kv4 channels
blocked by the α-KTx15 subfamily might have a canonical K+
channel pore structure.
Moreover, we also described a significant hERG-blocking
activity from the α-KTx15 toxins, as previously shown for
the γ-KTx peptides. AmmTx3 induced a hERG channel
block with no alteration of the gating kinetics. According
to a model of the γ-KTx toxin BeKm-1 from Buthus eupeus
docked on hERG channels, the toxin BeKm-1 is above the
pore entrance and none of its side chains penetrate deeply
into the pore. While α-KTx members usually interact with
channels through their β-sheets, γ-KTxs modulate hERG in
a different way than the one proposed for the interaction
between Charybdotoxin and the Shaker channel or between
KTX and the Kv1.3, in which the critical Lys27 protrudes
into the pore of the channel. BeKm-1 uses its α-helix
and the following turn (possessing two basic residues Lys18
and Arg20), to interact with hERG channel [58, 59]. In
contrast to the other α-KTx15 members, a new toxin of
this subfamily isolated from the Venezuelan scorpion Tityus
discrepans, called Discrepin (α-KTx15−6), was also able to
block an A-type K+ current in cerebellum granular cells in
culture, but was ineffective to block the hERG channel. Its
amino acid sequence displays only 50% identity with the
other members purified mainly from Old-World scorpion
venoms (Figure 4). Discrepin C-terminal β-sheet, supposed
to interfer with the Kv4 channel pore, presented a consensus
amino acid sequence similar to those found in the other
members (in grey on Figure 4), but its “hot spot” for hERG
channel blockade was altered. After several point mutations
in AmmTX3 and introduction of positive charged residues in
Discrepin, it was finally demonstrated that a common “hot
spot” composed of two basic residues (Arg18 and Lys19 near
the end of the α-helix) conferred hERG blockade activity of
α-KTx15 peptides [54]. From a structural point of view, we
proposed that two separate functional surfaces (A and B)
could coexist on the α-KTx15 toxins, and were responsible
for two different K+-current-blocking functions [60].
To extend our theory to other members from α-KTx
subfamily, the effects of a “hot spot-” bearing toxin were
tested on hERG channels and compared to the results
obtained with a toxin without the “hot spot.” From these
studies, it was concluded that only the α-KTxs possessing
the “hot spot” were able to interact with the pore of hERG
channels. This pharmacophore could either be -CKKX- or
-CKXK- or -CXKKX-, with C being the third Cys, X being
any nonpositively charged amino acid, and K being Lys or
Arg [54].
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Scorpion venom still remains a proven resource for the
discovery of novel biologically active compounds, especially
for the pharmacologists involved in research on ionic
channels. A total of about 210 α-KTx oligonucleotide or
amino acid sequences are now referenced in the UniProtKB
data bank, but only some of these α-KTx peptides have
really been shown able to block K+ currents. Unfortunately,
very often, there is no direct evidence described for the
function of the reported peptides. Some of them represent
new analogs of well-known families with described channel
selectivity, but others exhibit novel structural features or
activities. Majority of the α-KTx effects were determined
on the Kv1.x subfamily or in a less extent on the Ca2+-
activated K+ channels (SKCa sensitive to the bee venom
apamin or BKCa). During the last two decades, we obtained
a lot of results that provided new insight into the targets
and the mode of action of some α-KTxs isolated from
different potent North African Androctonus venoms. In par-
ticular, numerous studies on the Androctonus mauretanicus
mauretanicus venom “manually” extracted, which can be
considered as the physiological venom secretion, have greatly
contributed to the chemical, immunological, structural, and
pharmacological characterization of some highly specific K+
channel blockers. With AmmTX3, we have enlarged the α-
KTx15 subfamily and defined more properly its target, the
Kv4 channels. KTX, from the α-KTx3 subfamily, was finally
proven to be a powerful tool used by several international
teams to depict the molecular mechanisms of interaction
between K+ channels and peptide inhibitors, as well as to
demonstrate that the binding of K+ channel specific scorpion
toxins does not take place only on the outer vestibule of
the channel pore but also deeper into the selectivity filter.
The binding involves a combination of hydrophobic, hydro-
gen bonding and electrostatic interactions, which induces
significant structural rearrangements in both interacting
molecules. It was then proposed that structural flexibility
of the K+ channel and the toxin represent an important
determinant of the high specificity of toxin/K+ channel
interactions [13].
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